DCF — EINSTEIN MEDICAL CENTER MONTGOMERY
Enterprise Value: $143.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$143.4M
Enterprise Value
$35.2M
PV of Cash Flows
$108.2M
PV of Terminal Value
$174.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $284.6M | $21.0M | 7.0% | $5.5M | $5.0M |
| Year 2 | $293.1M | $24.5M | 8.0% | $7.8M | $6.5M |
| Year 3 | $301.9M | $28.3M | 9.0% | $10.3M | $7.8M |
| Year 4 | $311.0M | $30.7M | 10.0% | $11.8M | $8.1M |
| Year 5 | $320.3M | $32.4M | 10.0% | $12.8M | $7.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $143.4M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$276.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.06869942985782095
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5